Lead Candidate

It's time for another quarterly look at what Lead Candidate have been working on over the last three months! Swipe below to have a nosey ...⬇️ We've had an exciting quarter supporting the growth of our partners. Whether they're scaling up or strengthening their teams, we're priviledged to be part of their journey. We're committed to playing a part in this ever-evolving industry and assisting both our existing and new partners in achieving their goals. Interested in finding out how we could help your organisation? 📩 Get in touch at apply@leadcandidate.com 📲 Or book a consultation call here: https://lnkd.in/di8RNERy #TalentPartner #TalentAcquisition #CDMO

The latest episode of Molecule to Market with Raman Sehgal and Karen Lackey, CEO at X-Chem, Inc. is out! 🎙️ In this episode, Raman and Karen discuss: 👉 Why diversity of thought is essential in solving problems that have never been solved before 👉 Why did she leave the big pharma world after 30 years to join the world of academia? And how joining a global CRO enabled Karen to democratize its tech and platforms 👉 Why she's taking her decades of drug discovery experience to help redefine it at X-Chem 🎧 Listen here: https://lnkd.in/e6PGnXYi #Biotech #Biopharma #PharmaPodcast

CDMOs are increasingly fielding inquiries from biopharma clients on how reliant they are on China for their raw materials, off the back of industry anxiety on how the Biosecure Act would play out, manufacturing executives told Endpoints News. 💬 Stephen Houldsworth, VP and global head of platform management and marketing at Corden Pharma - A Full-Service CDMO said, "We have serious conversations with our customers over our raw material strategy." 💬 Aragen Life Sciences' Chief Commercial Officer Ashu Tandon said, "We've had customers coming in and saying, 'I want you to make this product for me. Tell me how much of a China dependency you have in that exactly." Tandon also noted that moving raw material supply isn't straightforward and the cost impact is at the forefront of manufacturers' agendas. 💊 The impact of the Biosecure Act combined with the Inflation Reduction Act is likely to add additional pressure to manufacturers and squeeze the cost of raw materials for affected drugs. #CDMO #DrugManufacturing #CPHI

Last night, we welcomed Susan Liu and Zara Stacey to the Lead Candidate team the only way we know how...with some friendly competition! 🎯 Virtual target practice is now up in the top three activities we've done this year - and we've done a lot! It's so exciting to watch the Lead Candidate team grow with more incredibly talented people, ready to support our customers around the world. And guess what! We're still looking for another Talent Partner to join us on this journey. So, if this looks like the sort of team evening you'd like to be a part of, check out the job role here: https://lnkd.in/eZAEUDtk #Team #CDMO #TalentPartner

Here's a snapshot of Megan and Tom enjoying a tour of INCOG's state-of-the-art facility with Staci Upmeyer Laski, SHRM-CP on their recent trip to Indiana. The visit was truly invaluable and couldn't have come at a more perfect time as INCOG BioPharma Services look to grow their team further! If you're interested in joining a #CDMO that does things differently, get in touch with Megan Peacock at megan@leadcandidate.com to have a chat! Here are just a few of the oppotunities to join the team: ⚙️ Senior QA Specialist ⚙️ QA Batch Specialist ⚙️ Method Transfer Scientist ⚙️ QA Compliance Specialist ⚙️ Quality Validation Specialist ⚙️ Specification Writer 👀 P.S. Stay tuned for more insights from the trip coming soon...📽️ 📸: Anna Powell Denton #FishersIN #Hiring

📢 Cellipont Bioservices, a leading cell therapy CDMO, announces Darren Head as CEO. 👉 With over 26 years of experience in biological, device, and drug manufacturing, as well as significant leadership in the CDMO sector, Head is well-equipped to guide Cellipont through its next phase of growth. 🗨️ "We are excited to have Darren as CEO in addition to his role of Chairman of the Board," said Noah Rhodes, a Cellipont Board Member and Head of Private Equity at GPP. "His deep familiarity with Cellipont's business, combined with his track record of success in the CGT CDMO space, makes him uniquely qualified to lead the company during this exciting period of growth. We are confident in his ability to continue guiding Cellipont along its growth trajectory." 🗨️ "I am honored to begin this new role as CEO and build upon the exciting work we've already accomplished together," said Darren Head. "Cellipont is at the forefront of an innovative and transformative industry, and I'm excited to lead our exceptional team as we continue to expand our capabilities, enhance client partnerships, and ultimately help bring life-changing therapies to patients in need." Congratulations to Darren and the Cellipoint team! #CDMO #CellTherapy #BioPharma

4 x new desks arrived ready for assembly at Lead Candidate HQ. If you're passionate about providing stunning customer service 🥇 and working in a culture thats all about quality and doing the right thing, then check out the link in the comments below ⬇️

Yes, we posted this back in August! Yes, we only just welcomed Deimantė last week! And yes, we're hiring again! We're looking for another Talent Partner to join our team and help support our partners in the pharma and bio outsourcing space. No recruitment experience needed, this is an entry-level position. All we ask is that you will relish the opportunity to learn and grow with us as we disrupt the recruitment industry for the better. 💷 £24,000 - £28,000 📍Newcastle Upon Tyne / Hybrid ➡️ Apply directly here: https://lnkd.in/eZAEUDtk #TalentPartner #TalentAcquisition #NorthEastJobs Andrew, Tom, Megan, Yasmine, Matt, Raman

🤝 CDMO Recipharm has signed a collaboration deal with U.S.-based Exela Pharma Sciences LLC to access its manufacturing plant in Lenoir, North Carolina. 💉 Exela is expanding the site to bolster its capabilities to produce biopharmaceuticals such as antibody-drug conjugates and other sterile products like vaccines. 🗨️ "We are excited about this strategic alliance with Exela, which significantly enhances our manufacturing footprint in the U.S.," Greg Behars, Recipharm's chief executive, said in the release. "This partnership aligns with our commitment to provide high-quality manufacturing solutions and expand our capabilities in the production of sterile products, such as GLP1, peptides, biologics, ADCs and other critical pharmaceuticals.' #CDMO #Biologics #PharmaNews

⭐ Commercial Director 📌 Remote, UK based 💷 £120,000 - £175,000 We're looking for an experienced commerical leader to provide strategic direction to an evolving commercial team at a UK based CDMO. The Commercial Director is responsible for developing and executing strategies across sales, marketing, customer management and development in support of growth. Does this sound like the career opportunity for you? 👀 ➡️ Send your resume to andrew@leadcandidate.com to apply 👉 Or find out more about this role here: https://lnkd.in/ejdeZex5 #CommercialDirector #Commercial #CDMO